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Introduction: Oral Verrucous Carcinoma (OVC) is described apart of the Squamous Cell Carcinoma (SCC) due to 
its specific properties. The objective of our study is to show our series of cases of OVC and to compare with the 
SCC in terms of clinical manifestations, epidemiology, histopathology, treatment and follow-up.
Material and Methods: This is a retrospective study of all the OVC treated in our department between January-
2007 and December-2011. The analyzed variables were sex, age, localization in the oral cavity, histopathology, 
number of biopsies needed to diagnose OVC, TNM classification, treatment and recurrences during follow-up. 
Results: Our sample was composed by n=14 patients, 57% female, with a mean age of 69.14 years. The most com-
mon localization was buccal mucosa (n=5). Seven patients were diagnosed of OVC with the first biopsy. TNM 
classification was: pT1: 7 patients, pT2: 3 patients, pT3: 3 patients, pT4: 1 patient. No cervical metastases were 
observed either in cervical neck dissection or during the follow-up of the patients. The treatment was surgery with 
clinical resection margins up to 1 cm in all cases, followed by radiotherapy in selected cases. Only n=1 patient 
(7.69%) presented a recurrence after 34 months of follow-up. The overall survival rate was 92.85%. 
Conclusions: In our population, OVC represents the 6.16% of all oral cavity and oropharynx cancer, and is more 
frequent in female patients above 70 years old. It uses to rise over a previous lesion, and usually affects the buccal 
mucosa. In patients with high suspicious lesions, more than one biopsy may be needed to diagnose OVC. No pa-
tient showed cervical dissemination. In our experience, treatment based on local resection, without cervical neck 
dissection, could be a good option for these patients.
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Introduction
The Verrucous Carcinoma was described by LV Acker-
man in 1948 (1) as an infrequent subtype of malignant 
disease which affects oral cavity. Usually, OVC presents 
a high tendency of local invasion, with a low tendency 
of dissemination, which varies depending on tumour 
size and evolution time (2), with a very low tendency to 
metastasize. Previous lesions as leucoplakias or eritro-
plakias, as well as Proliferative Verrucous Leucoplakia, 
are the sites where the OVC uses to arise from (3-5).  
Its etiology is not well known, but smoking habit, al-
cohol consumption and betel nut chewing are proved 
causes. The role of the Human Papilomavirus in OVC 
oncogenesis is much less important than in the SCC on-
cogenesis (6-8).  
Verrucous carcinoma usually debuts as an abnormal 
growth or as change in the consistency of a previous po-
tentially malignant disorder of the oral cavity. All mu-
cosal sites of the oral cavity can be affected. However, 
the rate of malignant transformation of a leukoplakia to 
an OVC is 20.81 times higher if they are located in the 
gingiva in comparison with the tongue (9).
Histopathologically, it frequently shows aneuploidy 
(10), which can be shown in conventional exfoliative 
cytology biopsies, which can be used as a marker of 
progression from potentially malignant disorder of the 
oral cavity to an OVC (Fig. 1).
Surgery is the best treatment. Although an optimal dis-
ease control can be achieved by surgery only, frequent 
revision is mandatory due to the increased risk of sec-
ond tumours (11). 
Our objective is to show our series of OVC patients, 
treated at our department, and to compare with the SCC 
in terms of clinical manifestations, epidemiology, his-
topathology, treatment and follow-up.
Material and Methods
We designed a descriptive and retrospective epidemio-
logical study of patients diagnosed of OVC and treated 
by surgery in our institution between January/2007 
and December/2011.
Between those years, we collected a total of 14 OVC 
patients, among n=227 patients diagnosed of SCC of 
the oral cavity, which met the following Inclusion Cri-
teria: pathological confirmation of OVC of the biopsied 
specimen of the resected tumor, surgical treatment and 
follow-up during more than 6 months. We excluded all 
patients who did not fit the inclusion criteria.
The analyzed variables were: sex, age, localization in the 
oral cavity, histopathology, number of biopsies needed 
to diagnose OVC, TNM classification (based on Ameri-
can Joint Committee on Cancer, 7th edition), treatment 
given and recurrences during follow-up. The statistical 
descriptive analysis was done using the SPSS v17.0.
 
Results
In our sample, 57% (n=8) were woman, and 43% (n=6) 
were males. The mean age was 69.14 years (range 84-
46). The most frequent localization was buccal mucosa 
(n=5 patients), followed by lip-commissure (n=3), gin-
giva (n=3), tongue (n=2) and hard palate (n=1). In n=2 
patients histopathological study revealed “hybrid verru-
cous carcinoma”. More epidemiological data are shown 
in table 1. Half of the patients (n=7) needed more than 
one biopsy to establish OVC diagnosis. Those previous 
biopsies were informed as epithelial hyperplasia (n=3), 
parakeratosis with acantosis (n=2), simple keratosis (n=2) 
and verrucous hyperplasia (n=1). The TNM classifica-
tion was pT1 (n=7), pT2 (n=3), pT3 (n=3), and pT4 (n=1). 
The treatment in all cases was local resection with clini-
cal margins above 1cm. In n=3 cases, a supraomohyoid 
cervical neck dissection were performed, and a radical 
neck dissection in n=1 case. The mean histopathological 
distance to deep resection margin was 5.35mm (median 
5.5mm). Radiotherapy was administered to T3 and T4 
patients and in patient #4 due to close histopathological 
margin (1 mm). The mean follow-up was 24.76 months 
(range 6-53 months). Data about surgery and follow-up 
are shown in table 2. Only n=1 patient (#6) died due a 
massive hemorrhage in his early postoperatory period, 
and was not considered to perform follow-up and re-
currence rate statistics. The recurrence rate was 7.69% 
(n=1/13 patients), which occurred after 34 months. The 
overall survival rate was 92.85% (13/14 patients). 
Fig. 1. General histopathological characteristics of the excised speci-
mens revealed acanthosis, papillomatosis, and hyperkeratosis of the 
epithelium of the lesion, continuing with characteristics of healthy 
mucosa. Squamous epithelial cell composition of the tumors did not 
give a definite atypical character, but showed blunt rete processes to-
ward the subepithelial area. Lymphocyte infiltration was noted in the 
periphery of the tumor islands. Hematoxylin-Eosin stain (H-E) 2x. 
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Discussion
The prevalence of OVC for total carcinomas affecting 
the oral cavity and oropharynx is low, and as revised in 
Rekha et al. (12), is between 2-12%. In our series, ver-
rucous carcinoma of the oral cavity, with respect to all 
patients with oral cavity cancer, represents the 6.16%, 
being in consonance with the reviewed literature. 
Published series on Asian patients, reflect its greater in-
cidence in men with prevalence as high as 77.4% (13) 
and 94.9% (14). This seems to be explained by consum-
er culture of betel nut and tobacco chewing. To the best 
of our known, no previous studies reflects the gender 
tendency of OVC in Spanish Caucasian population. In 
our sample, 57% were women, which can be in conso-
nant with a population without tobacco chewing habits. 
Numerous studies (12-15) indicate that OVC primarily 
affects patients between 40 and 60. The mean age at 
diagnosis in our patients was 69.14 years on average 
(median 71.5 years), which is almost 10-15 years later 
in our series than in the literature. The earlier affecta-
tion in these patients may be due, in the opinion of the 
authors, to an early onset in the consumption of carcino-
gens such as betel nut.
The involvement of buccal mucosa appears in several 
articles as the most common (12-14), as well as in our 
study (Fig. 2). Other authors have reported a greater in-
Patient Sex Age at diagnosis Localization TNM Histology 
1 Male 79 Buccal Mucosa T2N0M0 Pure OVC 
2 Female 52 Tongue T2N0M0 Pure OVC 
3 Female 77 Buccal Mucosa T3N0M0 Pure OVC 
4 Female 71 Gingiva T2N0M0 Pure OVC 
5 Male 84 Lower lip T1N0M0 Pure OVC 
6 Male 74 Gingiva T1N0M0 Pure OVC 
7 Male 75 Hard Palate T1N0M0 Pure OVC 
8 Female 62 Oral Commissure T1N0M0 Pure OVC 
9 Male 46 Oral Commissure T1N0M0 Pure OVC 
10 Male 80 Buccal Mucosa T3N0M0 Pure OVC 
11 Female 72 Buccal Mucosa T1N0M0 Pure OVC 
12 Female 59 Tongue T1N0M0 Pure OVC 
13 Female 65 Gingiva T4N0M0 Hybrid OVC 
14 Female 72 Buccal Mucosa T3N0M0 Hybrid OVC 
Table 1. Epidemiological description of the Oral Verrucous Carcinoma.
Patient Surgery Closest distance to  tumour (mm) 
Follow-up period 
(months) Recurrence 
1 Local resection 3 53 NO 
2 Local resection 3 51 NO 
3 Local resection and SOND 5 40 NO 
4 Local resection 1 38 NO 
5 Local resection 11 31 NO 
6 Local resection 4 1 (Died at early postop) NOT VALID 
7 Local resection 2 18 NO 
8 Local resection 6 13 NO 
9 Local resection 3 12 NO 
10 Local resection and SOND 9 10 NO 
11 Local resection 6 9 NO 
12 Local resection 8 7 NO 
13 Local resection and RND 6 6 NO 
14 Local resection and SOND 8 34 YES 
Table 2. Treatment and Follow-Up of the Oral Verrucous Carcinoma patients. SOND: Supra-Omohyoid Neck Dis-
section. RND: Radical Neck Dissection. 
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volvement of the lower lip (15,16), alveolar ridge and 
gingiva (3,17). The presence of a previous leukoplakia 
is also a constant (2-5,12,13). Some authors report diag-
noses like verrucous leukoplakia (17) or verrucous hy-
perplasia (18) in biopsies of long standing leukoplakia 
in which an OVC appeared later. In our study we found 
n = 7 OVC patients with previous verrucous leukopla-
kia in which subsequent biopsies were performed, with 
histopathological diagnoses similar to those described 
before. All our patients were treated by surgery. Local 
resection with 1 centimeter   of clinical margin is consid-
ered by many authors (19,20) as the treatment of choice 
for verrucous carcinoma. Although clinical margins 
were even greater than 1 cm, due to tissue retraction, 
histological margins were closer to the tumor. However, 
histological margins above 5 mm were considered suf-
ficient to not increase the risk of local recurrence (21). In 
patient #4, due to its closest free margin (1 mm) and the 
impossibility to increase resection margins in a second 
surgery, received postoperative radiotherapy. 
The need for a cervical dissection is also controversial. 
Case series published over the years agree that the OVC 
tends to grow locally but not to cause ganglionar spread 
(22,23). However, there are few published papers that 
refer of distant metastases as in the orbit (24) and ax-
illary lymph nodes (25). Thereby, cervical dissection 
should not be indicated in all cases of OVC. Because 
of an initial biopsy of SCC in patients #3 and #10, a 
Supraomohyoid Neck Dissection was performed due to 
the size of the tumor (T3 and T4), which were informed 
as negative (pN0) in both cases. Also T3 and T4 patients 
received radiotherapy after surgery.
We have identified an important diagnostic problem, 
which is the differentiation between “pure” OVC and 
“hybrid” OVC, which has foci of squamous cell carci-
noma. The hybrid OVC can be up to 20% of diagnosed 
OVC, and behaves like squamous cell carcinomas  re-
garding to their metastatic spreading tendency (26). 
In these cases, performing a cervical neck dissection 
is recommended, as if it were a squamous cell carci-
noma. In our series, in n=2 patients (patients #13 and 
#14), the histopathological study was informed as hy-
brid OVC, while the rest were pure OVC. One of these 
2 patients (patient #13) was diagnosed preoperatively of 
hybrid OVC, and due both to this diagnosis and to the 
size of the tumor (T4), underwent a Modified Radical 
Neck Dissection type III (preserving the Internal Jugu-
lar Vein, the Spinal Nerve and the Sternocleidomastoid 
Muscle) which was informed as negative (pN0). The 
other patient (case #14) had an initial biopsy of OVC, 
and underwent local wide resection, and after the his-
topathological study was reclassified as a hybrid OVC, 
and secondary performed a Supraomohyoid Neck Dis-
section which was informed as negative (pN0). Neither 
Fig. 2. Different localizations of OVC. Left: Buccal mucosa (patient #11). Right: Hard Palate (patient #7). 
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cases of hybrid OVC exhibited metastasis along the fol-
low-up (6 and 34 months, respectively). Also, as befits 
a pure OVC (20), no patient had cervical lymph node 
metastases, either in previous imaging studies, or in the 
histopathological studies in those who underwent pro-
phylactic neck dissection.
During the follow-up of our patients, only one patient 
had a local tumor recurrence 34 months after surgery in 
the buccal mucosa, biopsied as OVC again, and treated 
by surgery. No second tumors were found. Since the 
follow-up period was uneven for all patients, we can not 
state the recurrence rate at 5 years. Because the aver-
age follow-up was close to 2 years, we can say that the 
recurrence rate at 2 years of follow-up stood at 7.69%. 
The long-term follow-up studies of OVC patients refer 
highly variable recurrence rates between 0 and 66.7% 
at 5 years (13,15,19), which mostly depend on the type 
of treatment that has been given. Overall survival of the 
series was 92.85% (13/14 cases) for the follow-up pe-
riod described above. Survival of patients with OVC to 
5 years is between 93.65% (20) and 94.7% (19).
The most relevant limitation found in this article is the 
small size of the registered sample. Because our insti-
tution gives assistance to a population of a small city, 
the volume of oncological patients treated could be 
smaller than those that appear in other published series. 
Although n=14 patients represent a small sample, the 
prevalence of OVC among all SCC or the oral cavity in 
our series is similar to those published and referenced 
above. That is why we consider our sample as repre-
sentative. 
Conclusion
Verrucous carcinoma in our series appears in patients 
around 70 years, usually on a previous injury, often af-
fecting the buccal mucosa. In patients with suspicious 
lesions more than one biopsy to diagnose a verrucous 
carcinoma may be needed. No patient had cervical 
lymph node involvement. Local resection with at least 
5 mm of histological margin, without prophylactic neck 
dissection allows local control of the disease with recur-
rence rates of 7.69% at 2 years. Overall survival rate in 
our series was 92.85%.
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